Nav: Home

New clinical trial using water to treat polycystic kidney disease

January 28, 2018

A cheap, safe and effective treatment to polycystic kidney disease may soon be available, thanks to a new national clinical out of Westmead, Australia, which is trialing water to treat the disease.

The trial, known as PREVENT-ADPKD, will investigate whether drinking the right amount of can prevent adult polycystic kidney disease (ADPKD) progressing to kidney failure.

ADPKD is an inherited disease in which the kidneys deteriorate because of cysts that grow and destroy healthy tissue.

The study team - led by Dr Annette Wong, Carly Mannix, Professor David Harris and Dr Gopi Rangan - at the Westmead Hospital and the Westmead Institute for Medical Research are optimistic that drinking water is an effective treatment to reduce kidney cyst growth in ADPKD patients.

"Water stops the hormone that makes these cysts grow, so ensuring you aren't thirsty reduces the chance of cysts growing,"Dr Rangan said.

"This is important, because there is no cure for polycystic kidney disease. More than 50 per cent of patients eventually develop kidney failure, requiring dialysis or kidney transplantation.

"If successful, our approach could have major benefits for the health of people with ADPKD. If we can slow the disease at an early stage, we could potentially prevent kidney failure occurring altogether.

"A positive study result will show that water is a cheap, safe and effective treatment," he explained.

The team's previous research showed that increased water intake was highly effective at reducing cyst growth in animals with polycystic kidney disease.

This new study protocol, published in BMJ Open, will be the first of its kind to provide evidence on whether prescribed water intake is an effective treatment for ADPKD in humans. The three-year randomised controlled clinical trial will use MRI to assess the rate of cyst growth in the kidney throughout the study.

Patients with ADPKD develop hundreds of cysts in the kidney, which form in early childhood and grow by five to ten per cent each year. It is the most common genetic kidney disease in adults, affecting one in every 2500 individuals. More than 2000 Australians with ADPKD currently receive dialysis or need a kidney transplant.

More than 240 people have already enrolled in the trial, and full results will be available in 2020.
Recruitment for the study closes on 28 February 2018. Participants interested in participating in the trial should contact the study team by email:

The study protocol is available online at BMJ Open:

Westmead Institute for Medical Research

Related Kidney Failure Articles:

Novel treatment offers kidney failure patients with rare disorder new hope
A novel treatment offers kidney failure and kidney transplant patients with a rare disorder new hope.
Study quantifies kidney failure risk in living kidney donors
Researchers have developed a risk calculator that estimates the risk of kidney failure after donation.
Potential new treatment for kidney failure in cancer patients
Kidney dysfunction is a frequent complication affecting more than 50 percent of all cancer patients, and is directly linked to poor survival.
Testing urine for particular proteins could be key to preventing kidney transplant failure
Testing for molecular markers in the urine of kidney transplant patients could reveal whether the transplant is failing and why, according to research presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases.
HIV+ kidney failure patients face hurdles in receiving necessary transplants
From 2001 to 2012, HIV+ kidney failure patients on the transplant waiting list were 28 percent less likely to receive a transplant compared with their HIV- counterparts.
Researchers study care for undocumented immigrants with kidney failure
By failing to provide scheduled dialysis treatments to undocumented immigrants with kidney failure, states pay higher costs for care and the patients face greater pain and psychological distress, according to a new study appearing in the latest issue of the journal JAMA Internal Medicine.
Kidney failure patients' advance directives are often inadequate
In a recent study, nearly half of kidney failure patients receiving dialysis had advance directives outlining their preferences related to end-of-life care, but only a very small minority of these directives addressed the management of dialysis.
New strategy may help prevent kidney failure in patients with diabetes
A new strategy may help halt the progression of kidney disease in patients with diabetes.
Metabolite secreted in urine may cause cognitive impairment in kidney failure patients
Retention of certain metabolites in the blood may contribute to cognitive impairment in patients with kidney failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.
Female hormones may make women less susceptible to kidney failure than men
Researchers detected transient increases in enzymes indicative of kidney health that correlated with specific phases of the female reproductive hormone cycle.

Related Kidney Failure Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...